PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
1.52 - 1.58
1.19 - 3.37
354.5K / 984.1K (Avg.)
-1.64 | -0.94
Steady, sustainable growth is a hallmark of high-quality businesses. Value investors watch these metrics to confirm that the company's fundamental performance aligns with—or outpaces—its current market valuation.
-20.13%
Negative revenue growth while ENPH stands at 27.74%. Joel Greenblatt would look for strategic missteps or cyclical reasons.
-41.85%
Negative gross profit growth while ENPH is at 53.00%. Joel Greenblatt would examine cost competitiveness or demand decline.
83.00%
EBIT growth above 1.5x ENPH's 40.48%. David Dodd would confirm if core operations or niche positioning yield superior profitability.
84.65%
Operating income growth above 1.5x ENPH's 40.48%. David Dodd would confirm if consistent cost or pricing advantages drive this outperformance.
77.59%
Net income growth above 1.5x ENPH's 22.84%. David Dodd would check if a unique moat or cost structure secures superior bottom-line gains.
77.72%
EPS growth at 75-90% of ENPH's 97.06%. Bill Ackman would push for improved profitability or share repurchases to catch up.
77.72%
Diluted EPS growth at 75-90% of ENPH's 97.06%. Bill Ackman would expect further improvements in net income or share count reduction.
-0.54%
Share reduction while ENPH is at 2514.16%. Joel Greenblatt would see if the company has a better buyback policy than the competitor.
-0.54%
Reduced diluted shares while ENPH is at 2514.16%. Joel Greenblatt would see a relative advantage if the competitor is diluting more.
No Data
No Data available this quarter, please select a different quarter.
521.21%
OCF growth 1.25-1.5x ENPH's 425.30%. Bruce Berkowitz would see if superior pricing or efficient operations explain the gap.
2000.43%
FCF growth above 1.5x ENPH's 277.77%. David Dodd would verify if the firm’s strategic investments yield superior returns.
7082.42%
Positive 10Y revenue/share CAGR while ENPH is negative. John Neff might see a distinct advantage in product or market expansion over the competitor.
409.62%
Positive 5Y CAGR while ENPH is negative. John Neff might see an underappreciated edge for the firm vs. the competitor.
15.78%
Positive 3Y CAGR while ENPH is negative. John Neff might view this as a sharp short-term edge or successful pivot strategy.
5951.95%
10Y OCF/share CAGR above 1.5x ENPH's 111.89%. David Dodd would check if a superior product mix or cost edge drives this outperformance.
311.99%
5Y OCF/share CAGR above 1.5x ENPH's 111.89%. David Dodd would confirm if the firm has better cost structures or brand premium boosting mid-term cash flow.
141.29%
3Y OCF/share CAGR 1.25-1.5x ENPH's 111.89%. Bruce Berkowitz might see if strategic cost controls or product mix drove recent gains.
-498.12%
Negative 10Y net income/share CAGR while ENPH is at 97.73%. Joel Greenblatt sees a major red flag in long-term profit erosion.
-595.14%
Negative 5Y net income/share CAGR while ENPH is 97.73%. Joel Greenblatt would see fundamental missteps limiting profitability vs. the competitor.
-331.67%
Negative 3Y CAGR while ENPH is 97.73%. Joel Greenblatt might call for a short-term turnaround strategy or cost realignment.
No Data
No Data available this quarter, please select a different quarter.
75.78%
Positive 5Y equity/share CAGR while ENPH is negative. John Neff might see a clear edge in retaining earnings or managing capital better.
2.84%
Positive short-term equity growth while ENPH is negative. John Neff sees a strong advantage in near-term net worth buildup.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-27.31%
Firm’s AR is declining while ENPH shows 1.15%. Joel Greenblatt sees stronger working capital efficiency if sales hold up.
4.77%
Inventory growth well above ENPH's 9.45%. Michael Burry suspects overshooting production or weaker sell-through vs. the competitor.
3.87%
Asset growth well under 50% of ENPH's 40.84%. Michael Burry sees the competitor as far more aggressive in building resources or capacity.
-5.96%
Both erode book value/share. Martin Whitman suspects a difficult environment or poor capital deployment for both players.
0.76%
We have some new debt while ENPH reduces theirs. John Neff sees the competitor as more cautious unless our expansions pay off strongly.
-5.33%
Our R&D shrinks while ENPH invests at 11.65%. Joel Greenblatt checks if we risk falling behind a competitor’s new product pipeline.
0.03%
SG&A declining or stable vs. ENPH's 13.74%. David Dodd sees better overhead efficiency if it doesn't hamper revenue.